ASH – 2021 – Poster Presentation 3818
Publications
December 11, 2021
Knock Out of CD123 or CLL-1 by CRISPR-Cas9 Editing From Human Hematopoietic Stem Cell Transplantations Provide New Possibilities for Increasing Therapeutic Index and Safety for AML Treatment
Platform
Presented by: Preclinical and Translational Biology Team – Vor Bio